The costimulatory molecules CD80, CD86 and OX40L are up-regulated in Aspergillus fumigatus sensitized mice

Clinical and Experimental Immunology

Volumn 142, Issue 2, 2005, Pages 242-250

  Barrios, C S ^a   Johnson, B D ^a   Henderson Jr , J D ^a   Fink, J N ^a   Kelly, K J ^a   Kurup, Viswanath P ^a,b,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Research Service   (United States)

Author keywords

Aspergillus induced allergy; Cell surface molecules; Murine model; T cells; Th1 Th2 cells

Indexed keywords

ALLERGEN; B7 ANTIGEN; CD134 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1 ANTIBODY; INTERLEUKIN 4; OX 40 L ANTIGEN; RECOMBINANT INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; B LYMPHOCYTE ACTIVATION; BRONCHOPULMONARY ASPERGILLOMA; COMPARATIVE STUDY; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; IMMUNE RESPONSE; LUNG ALVEOLUS MACROPHAGE; MOLECULE; MOUSE; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SENSITIZATION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION;

ALLERGENS; ANIMALS; ANTIGENS, CD80; ANTIGENS, CD86; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; CELLS, CULTURED; CYTOKINES; EOSINOPHILIA; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; SPLEEN; TUMOR NECROSIS FACTORS; UP-REGULATION;

EID: 27644433870     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02905.x     Document Type: Article

References (44)

1. Greenberger PA. Allergic bronchopulmonary aspergillosis. In: Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER, eds. Middletonís Allergy Principles and Practice. St Louis: Mosby, 2003:1353-71.
2. Knutsen AP, Chauhan B, Slavin RG. Cell-mediated immunity in allergic bronchopulmonary aspergillosis. In: Kurup VP, Apter AJ, eds. Immunology and Allergy Clinics of North America. Philadelphia: W.B. Saunders, 1998:575-99.
3. Kurup VP, Madan T, Sarma UP. Allergic bronchopulmonary aspergillosis. Recent concepts and considerations. In: Domer JE, Kobayashi GS, eds. The Mycota XII. Human Fungal Pathogens. Berlin: Springer-Verlag, 2004:225-41.
4. Abbas AK. The control of T cell activation vs. tolerance. Autoimmun Rev 2003; 2:115-8.
5. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005; 23:515-48.
6. Chapoval SP, David CS. CD28 costimulation is critical for experimental allergic asthma in HLA-DQ8 transgenic mice. Clin Immunol 2003; 106:83-94.
7. Coyle AJ, Gutierrez-Ramos JC. The role of ICOS and other costimulatory molecules in allergy and asthma. Springer Semin Immunopathol 2004; 25:349-59.
8. Deurloo DT, van Berkel MA, van Esch BC, Hofhuis F, Nijkamp FP, Oosterwegel MA, van Oosterhout AJ. CD28/CTLA-4 double deficient mice demonstrate crucial role for B7 co-stimulation in the induction of allergic lower airways disease. Clin Exp Allergy 2003; 33:1297-304.
9. El Biaze M, Boniface S, Koscher V et al. T cell activation, from atopy to asthma: more a paradox than a paradigm. Allergy 2003; 58:844-53.
10. Mark DA, Donovan CE, De Sanctis GT et al. B7-1 (CD80) and B7-2 (CD86) have complementary roles in mediating allergic pulmonary inflammation and airway hyperresponsiveness. Am J Respir Cell Mol Biol 2000; 22:265-71.
11. Mathur M, Herrmann K, Qin Y et al. CD28 Interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice. Am J Resp Cell Mol Biol 1999; 21:498-509.
12. Zdolsek HA, Jenmalm MC. Expression of the T-cell markers CD2 and CD28 in healthy and atopic children during the first 18 months of life. Pediatr Allergy Immunol 2003; 14:169-77.
13. Bugeon L, Dallman MJ. Costimulation of T Cells. Am J Resp Crit Care Med 2000; 162:5164-8.
14. Haczku A, Takeda K, Redai I et al. Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1999; 159:1638-43.
15. Krinzman SJ, De Sanctis GT, Cernadas M et al. Inhibition of T cells costimulation abrogates airway hyperresponsiveness in a murine model. J Clin Invest 1996; 98:2693-9.
16. Gramalia IA, Weinberg D, Lemon M, Croft M. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol 1998; 161:6510-7.
17. Murata K, Ishii N, Takano H, Miura S, Ndhlovu LC, Nose M, Noda T, Sugamura K. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J Exp Med 2000; 191:365-74.
18. Burgess JK, Carlin S, Pack RA, Arndt GM, Au WW, Johnson PR, Black JL, Hunt NH. Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? J Allergy Clin Immunol 2004; 113:683-9.
19. Burgess JK, Blake AE, Boustany S, Johnson PR, Armour CL, Black JL, Hunt NH, Hughes JM. CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol 2005; 115:302-8.
20. Salek-Ardakani S, Song J, Halteman BS, Jember AG, Akiba H, Yagita H, Croft M. OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med 2003; 198:315-24.
21. Hoshino A, Tanaka Y, Akiba H et al. Critical role for OX40 ligand in the development of pathogenic Th2 cells is a murine model of asthma. Eur J Immunol 2003; 33:861-9.
22. Arestides RS, He H, Westlake RM, Chen AI, Sharpe AH, Perkins DL, Finn PW. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol 2002; 32:2874-80.
23. Jember AG, Zuberi R, Liu FT, Croft M. Development of Allergic Inflammation in a Murine Model of Asthma is Dependent on the Costimulatory Receptor OX40. J Exp Med 2001; 193:387-92.
24. Kim MY, Bekiaris V, McConnell FM, Gaspal FM, Raykundalia C, Lane PJ. OX40 Signals during Priming on Dendritic Cells Inhibit CD4 T Cell Proliferation: IL-4 Switches off OX40 Signals Enabling Rapid Proliferation of Th2 Effectors. J Immunol 2005; 174:1433-7.
25. Kurup VP, Grunig G. Animal models of allergic bronchopulmonary aspergillosis. Mycopathologia 2002; 153:165-77.
26. Kurup VP, Mauze S, Choi H, Seymour BW, Coffman RL. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J Immunol 1992; 148:3783-8.
27. Kurup VP, Xia JQ, Crameri R et al. Purified recombinant A. fumigatus allergens induce different responses in mice. Clin Immunol 2001; 98:327-36.
28. Banerjee B, Greenberger PA, Fink JN, Kurup VP. Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect Immunity 1998; 66:5175-82.
29. Kurup VP, Banerjee B, Hemmann S, Greenberger PA, Blaser K, Crameri R. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 2000; 30:988-93.
30. Kurup VP, Xia JQ, Rickaby DA, Dawson CA, Choi H, Fink JN. Aspergillus fumigatus antigen exposure in pulmonary airway resistance in wild-type but not in IL- 4 knockout mice. Clin Immunol 1999; 90:404-10.
31. Barrios C, Brawand P, Berney M, Brandt C, Lambert PH, Siegrist CA. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 1996; 26:1489-96.
32. Rathore VB, Johnson B, Fink JN, Kelly KJ, Greenberger PA, Kurup VP. T cell proliferation and cytokine secretion to T cell epitopes of Asp f 2 in ABPA patients. Clin Immunol 2001; 100:228-35.
33. Siegrist CA, Córdova M, Brandt C, Barrios C, Berney M, Tougne C, Kovarik J, Lambert P-H. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine 1998; 16:1409-14.
34. Kurup VP, Choi HY, Murali PS, Xia JQ, Coffman RL, Fink JN. Immune responses to Aspergillus antigen in IL-4-/- mice and the effect of eosinophils ablation. Allergy 1999; 54:420-7.
35. Johnson BD, Yan X, Schauer DW, Orentas RJ. Dual expression of CD80 and CD86 produce a tumor vaccine superior to single expression of either molecule. Cellular Immunol 2003; 222:15-26.
36. Khan S, McClellan JS, Knutsen AP. Increased sensitivity to IL-4 in patients with Allergic Bronchopulmonary Aspergillosis. Int Arch Allergy Immunol 2000; 123:319-26.
37. Knutsen AP, Hutchinson PS, Albers GM, Consolino J, Smick J, Kurup VP. Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 2004; 59:81-7.
38. Knutsen AP. Lymphocytes in allergic bronchopulmonary aspergillosis. Front Biosci 2003; 8:589-602.
39. Skov M, Poulsen LK, Koch C. Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis. Pediatr Pulmonol 1999; 27:74-9.
40. Cerutti A, Zan H, Schaffer A, Bergsagel L, Harindranath N, Max EE, Casali P. CD40 ligand and appropriate cytokines induce switching to IgG, IgA and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol 1998; 160:2145-57.
41. Jeannin P, Delneste Y, Lecoanet-Henchoz S, Gacuchat JF, Ellis J, Bonefoy JY. CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells. J Biol Chem 1997; 272:15613-9.
42. Nakajima A, Watanabe N, Yoshino S, Yagita H, Okumura K, Azuma M. Requirement of CD28/CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int Immunol 1997; 9:637-44.
43. Tsuyuki S, Tsuyuki J, Einsle K, Kopf M, Coyle AJ. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med 1997; 185:1671-9.
44. Jirapongsananuruk O, Hofer MF, Trumble AE, Norris DA, Leung DYM. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis. J Immunol 1999; 160:4622-7.